- Keywords > antibacterial resistance (ABR)
- Keywords > antibiotic resistance
- Keywords > antimicrobial resistance (AMR)
- Keywords > antimicrobial resistance surveillance
- Keywords > consumption of antimicrobial medicines
- Keywords > containment of antimicrobial resistance
- Keywords > drug resistance, microbial
- Keywords > resistance - antibacterial drugs
- Keywords > surveillance - antibiotic resistance and antibiotic use
- Keywords > confinement antimicrobien
(2017; 84 pages)
Antimicrobial resistance (AMR) is a global public health concern that threatens the health of the population as well as the economic development of the countries. Antibiotic resistance occurs naturally, but inappropriate use of antibiotics in humans and animals is accelerating the process. Thus, regular monitoring of antimicrobial consumption (AMC) in countries and establishing reliable surveillance system are critical. The Action Agenda for Antimicrobial Resistance in the Western Pacific Region and the Global Action Plan on Antimicrobial Resistance highlight the importance of improving surveillance of AMR and monitoring of AMC.
In order to do this, the World Health Organization (WHO) is assisting countries to improve their capacity to monitor AMC through a range of interventions such as development of standards and methodologies throughout the Region. The Organization is also supporting the establishment of monitoring centres as well as the inclusion of AMC in the policy and legal framework.
The Workshop on Monitoring Antimicrobial Consumption in Select Western Pacific Countries, held in Manila, Philippines, from 30 to 31 March 2017 was organized by WHO, focusing on the development of standards and methodologies for AMC monitoring. Participants included technical experts and national AMR focal points from the ministries of health of nine countries and areas in the Western Pacific Region. Bringing together relevant experts and development partners provided a unique opportunity to accelerate progress towards harmonization of standards and methodologies for AMC monitoring throughout the Region. The meeting also reviewed current practices on how AMC is monitored in different country system settings and provided a forum for discussions on sharing of national data. The meeting additionally provided opportunities for exchange of lessons learnt and fostered future collaborations.
Among other issues, the workshop highlighted:
- the importance of generating reliable and comparable national consumption data over time and across countries;
- the need for collecting information on the level of use and types of antimicrobials used;
- the role of legislation and particularly its importance in balancing the access to effective antimicrobials and regulating their inappropriate use; and
- the importance of interpreting and applying the AMC data to guide the AMR interventions.